CIK 0001739104
- Large accelerated filer
Elanco Animal Health Inc
Sign in to watch- Ticker
- ELAN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825497352
- Phone
- +1 877-352-6261
- Business address
- 450 ELANCO CIRCLE, INDIANAPOLIS, IN, 46221
- Open-market buys, last 90 days
- $935,920
- in 1 filing
- Open-market sales, last 90 days
- $100,050
- in 1 filing, $100K under 10b5-1 plans
Net +$835,870. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-29 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +217.96 | $32.88 | $7K | 7,897.79 |
| 2021-10-29 | Anand Kapila K Director | Grant or award · Deferred Stock Units | +111.52 | $32.88 | $4K | 1,122.51 |
| 2021-10-20 | Cabral Ramiro Martin See Remarks | Shares withheld for taxes | −1,995 | $33.66 | $67K | 54,377 |
| 2021-10-20 | Kinard David S See Remarks | Shares withheld for taxes | −2,065 | $33.66 | $70K | 75,378 |
| 2021-10-20 | Schacht Aaron L Executive Vice President | Shares withheld for taxes | −2,065 | $33.66 | $70K | 78,747 |
| 2021-10-20 | Simmons Jeffrey N President, CEO and Director | Shares withheld for taxes | −15,814 | $33.66 | $532K | 552,763 |
| 2021-10-20 | Urbanek David Alan See Remarks | Shares withheld for taxes | −3,042 | $33.66 | $102K | 70,242 |
| 2021-09-30 | Anand Kapila K Director | Grant or award · Deferred Stock Units | +114.98 | $31.89 | $4K | 1,011 |
| 2021-09-30 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +224.73 | $31.89 | $7K | 7,679.83 |
| 2021-09-30 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +224.73 | $31.89 | $7K | 8,158.38 |
| 2021-09-30 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +486.05 | $31.89 | $16K | 17,644.85 |
| 2021-08-31 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +214.7 | $33.38 | $7K | 7,933.65 |
| 2021-08-31 | BILBREY JOHN P Director | Grant or award · Deferred Stock Units | +214.7 | $33.38 | $7K | 7,455.07 |
| 2021-08-31 | Anand Kapila K Director | Grant or award · Deferred Stock Units | +109.85 | $33.38 | $4K | 896.02 |
| 2021-08-31 | HOOVER R DAVID Director | Grant or award · Deferred Stock Units | +464.35 | $33.38 | $15K | 17,158.81 |
| 2021-08-16 | HOOVER R DAVID See Remarks | Purchase | +8,000 | $31.45 | $252K | 90,000 |
| 2021-08-13 | HOOVER R DAVID See Remarks | Purchase | +2,000 | $30.75 | $61K | 82,000 |
| 2021-08-11 | Harrington Michael J Director | Purchase | +3,000 | $28.99 | $87K | 25,684 |
| 2021-08-11 | Simmons Jeffrey N President, CEO & Director | Purchase | +16,850 | $29.70 | $500K | 568,577 |
| 2021-07-30 | Kurzius Lawrence Erik Director | Grant or award · Deferred Stock Units | +196.51 | $36.37 | $7K | 7,718.95 |
Page 34 of 35 · 697 trades